MARIA HORTON: Open Payments
NPI 1528519956 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 69 payments from 14 companies in 2025. Trend: 2023 $253 · 2024 $375 · 2025 $1,103
Food & beverage: $1,103
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $217 |
| Lundbeck LLC | 20 | $187 |
| Otsuka America Pharmaceutical, Inc. | 14 | $168 |
| Vanda Pharmaceuticals Inc. | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| ABBVIE INC. | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 3 | $43 |
| Axsome Therapeutics, Inc. | 2 | $42 |
Products named: REXULTI, ARISTADA, FANAPT, COBENFY, VRAYLAR, VIVITROL, CAPLYTA, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
